Alphatec sees FY26 revenue $890M, consensus $886.86M

The company said, “The Company anticipates full-year 2026 total revenue of $890 million, reflecting growth of approximately 17% compared to the full year 2025. This includes expected surgical revenue of approximately $805 million and approximately $85 million of EOS revenue. The Company also expects adjusted EBITDA of approximately $130 million, which will contribute to an expected $20 million of free cash flow for the full year 2026.”